Menu

 

All Sites Sorted » Health Beauty and Fitness » Medicine


 


Sponsored

 

Latest News

Will Ligand Pharmaceuticals Beat Q3 Earnings Estimates?
Ligand Pharmaceuticals Incorporated (LGND), which is scheduled to report third-quarter 2014 results on Oct 27, had posted a positive earnings surprise of 25% last quarter. Fri, 24 Oct 2014 13:00:02 -0700

Will Vertex Pharmaceuticals (VRTX) Post a Lower Q3 Loss?
Vertex Pharmaceuticals (VRTX) is likely to beat earnings expectations in the third quarter of 2014. Fri, 24 Oct 2014 12:11:42 -0700

Vertex Pharmaceuticals' EPS Estimates Improved In Past Month
In the month leading up to the Vertex Pharmaceuticals' third quarter earnings announcement slated for Tuesday, October 28, 2014, expectations have risen for the upcoming results. The consensus analyst estimate has gone from a loss of 61 cents per share to the current projection of a loss of 57 cents Fri, 24 Oct 2014 07:46:48 -0700

Research and Markets: Pharmaceuticals: 2014 Scandinavia Industry Guide for the $9.7 Billion Industry
Research and Markets has announced the addition of the "Pharmaceuticals: Scandinavia Industry Guide" report to t Fri, 24 Oct 2014 07:16:00 -0700

Elite Pharmaceuticals Announces New Management Appointments
NORTHVALE, N.J. -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") ,a specialty pharmaceutical company developing a pipeline of abuse-deterrent opioids and niche generic products, ... Fri, 24 Oct 2014 04:15:00 -0700

Sucampo Pharmaceuticals, Inc. Announces Third Quarter 2014 Earnings Call
BETHESDA, Md. -- Sucampo Pharmaceuticals, Inc. (Sucampo) , a global biopharmaceutical company, today announced that it will host its third quarter 2014 financial results teleconference and webcast at 8:30 ... Fri, 24 Oct 2014 03:45:00 -0700

Merrimack Pharmaceuticals (MACK) Looks Strong: Stock Up 8.6%
Merrimack Pharmaceuticals (MACK) was a big mover last session, as the company saw its shares jump nearly 9% on the day Fri, 24 Oct 2014 03:35:02 -0700

Arbor Pharmaceuticals Announces FDA Approval of Sotylize™
ATLANTA, Oct. 23, 2014 /PRNewswire/ -- Arbor Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Sotylize (sotalol hydrochloride) oral solution. Sotylize is the first and only sotalol oral solution indicated for the treatment of documented life-threatening ventricular arrhythmias and the maintenance of normal sinus ... Thu, 23 Oct 2014 11:58:00 -0700

Why Highbridge initiates a new position in Valeant Pharmaceuticals
Highbridge Capital initiated a brand new position in Valeant Pharmaceuticals (VRX). Valeant Pharmaceuticals accounts for 0.47% of the fund's second quarter portfolio. Thu, 23 Oct 2014 06:00:36 -0700

Cubist Pharmaceuticals' Q3 Earnings Beat Expectations
Cubist Pharmaceuticals (CBST) third-quarter 2014 earnings of 58 cents per share were well ahead of the Zacks Consensus Estimate of 36 cents. Thu, 23 Oct 2014 06:00:02 -0700

Website Directory Sort by: Hits | Alphabetical

Features

Top 5 Web Hosts
(Largest)


Top 5 Favorite Web Hosts

   1. HostGator
   2. LunarPages
   3. Yahoo! Web Hosting
   4. HostMonster
   5. BlueHost